Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
CALX Calix rises 303 percent after reporting 203 percent year over year Q4 2025 revenue growth Is BRC Group RILYZ stock forming a bearish structure BRC Group Posts 171 EPS No Estimates No Revenue Released CrossTimbers CRT Stock ETF Trade 169 20260423 The long term thesis for FreeportMcMoRan FCX in plain sight Ticks Up 20260511 Dow Inc DOW How Photronics PLAB manages counterparty exposure Q1 2026 Better Than Expected Amcor plc XLB Diverging Market Sentiment Amid Sector Underperformance and Upbeat Operational Guidance EQX Equinox delivers better than expected Q4 2025 earnings sending shares nearly four percent higher on the day NTAP NetApp Q1 2026 EPS edges past consensus estimates shares rise 118 percent on positive investor sentiment Consumer Sentiment Plunges to AllTime Low as Iran War Drives Gasoline Prices Higher Energys ENGS Stock Up 563 Key Resistance at 158 20260519 Is Belite Bio BLTE Undervalued at 14248 20260518 Paymentus Holdings PAY Q1 2026 Earnings Beat Revenue NA EPS 021 LexinFintech LX Up 233 Is There More Room to Run 20260520 Apollo Micro Systems Shares Rally 22 After Strong Quarterly Results Samsung Electronics Faces Strike as 47000 Workers Prepare to Walk Out Shares Decline Willis WTW Delivers Q1 2026 Beat EPS 372 vs 370 Expected RZB Q1 2026 Earnings Strong EPS Beat Driven by Underlying RGA Performance CIMN Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Lower FUBO Q1 2026 Earnings Narrower Loss Drives Significant EPS Beat Algorhythm Holdings Inc Q1 2026 Earnings Narrowed Loss Beats Estimates but Stock Declines on Revenue Uncertainty MLM Q1 2026 Earnings EPS Slightly Misses Estimates Stock Gains on Resilient Demand DWS Municipal Income Trust KTF Holds Steady Near 9 as Support and Resistance Levels Define Range Wabash National Corporation WNC Edges Higher Amid Modest Volume Key Levels to Watch Alphabet Inc GOOG Slightly Pulls Back Amid Broader Market Caution Kyverna Therapeutics KYTX Faces Selling Pressure as Stock Nears Key Support at 824